Literature DB >> 11850294

Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections.

P Villani, M B Regazzi, F Marubbi, P Viale, L Pagani, F Cristini, B Cadeo, G Carosi, R Bergomi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11850294      PMCID： PMC127516          DOI： 10.1128/AAC.46.3.936-937.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.

Authors:  R Hachem; C Afif; Z Gokaslan; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-06       Impact factor: 3.267

Review 2.  Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review.

Authors:  Z H Shaikh; C A Peloquin; C D Ericsson
Journal:  Scand J Infect Dis       Date:  2001

3.  Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography.

Authors:  G W Peng; R P Stryd; S Murata; M Igarashi; K Chiba; H Aoyama; M Aoyama; T Zenki; N Ozawa
Journal:  J Pharm Biomed Anal       Date:  1999-06       Impact factor: 3.935

Review 4.  Linezolid: a review of its use in the management of serious gram-positive infections.

Authors:  C M Perry; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model.

Authors:  P Cottagnoud; C M Gerber; F Acosta; M Cottagnoud; K Neftel; M G Täuber
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

6.  Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison.

Authors:  C G Gemmell
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

Review 7.  Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.

Authors:  C Zeana; C J Kubin; P Della-Latta; S M Hammer
Journal:  Clin Infect Dis       Date:  2001-07-11       Impact factor: 9.079

8.  [Epidemiological study of nosocomial meningitis in neurological patients].

Authors:  M I Ostabal; M A Suárez Pinilla; C Sanz Sebastián; A Millastre
Journal:  Rev Neurol       Date:  1996-03       Impact factor: 0.870
  8 in total
  17 in total

1.  Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.

Authors:  Wolfgang A Krueger; Bernd Kottler; Bernd E Will; Alexandra Heininger; Heinz Guggenberger; Klaus E Unertl
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Effective CSF concentrations achieved with continuous-infusion flucloxacillin in a child.

Authors:  Alison Boast; Jeremy Carr; Nigel Curtis; Andrew J Daley; Amanda Gwee
Journal:  Eur J Clin Pharmacol       Date:  2015-08-26       Impact factor: 2.953

3.  Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.

Authors:  Ronny Beer; Klaus W Engelhardt; Bettina Pfausler; Gregor Broessner; Raimund Helbok; Peter Lackner; Christian Brenneis; Stefan T Kaehler; Apostolos Georgopoulos; Erich Schmutzhard
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry.

Authors:  Sooraj Baijnath; Adeola Shobo; Linda A Bester; Sanil D Singh; Gert Kruger; Per I Arvidsson; Tricia Naicker; Thavendran Govender
Journal:  J Mol Histol       Date:  2016-06-21       Impact factor: 2.611

5.  Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

Authors:  Pavlos Myrianthefs; Sophia L Markantonis; Konstantinos Vlachos; Maria Anagnostaki; Eleni Boutzouka; Dimitris Panidis; Georgios Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

Review 6.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

8.  Treatment with linezolid in a neonate with meningitis caused by methicillin-resistant Staphylococcus epidermidis.

Authors:  Shinichi Watanabe; Akihiro Tanaka; Tomoko Ono; Masaaki Ohta; Hitoshi Miyamoto; Hisamichi Tauchi; Mamoru Tanaka; Katsuya Suemaru; Hiroaki Araki
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

Review 9.  Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.

Authors:  Claire Roger; Jason A Roberts; Laurent Muller
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

10.  Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.

Authors:  Ryuichi Hirano; Yuichi Sakamoto; Naoki Tachibana; Motoki Ohnishi
Journal:  Int J Clin Pharm       Date:  2014-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.